For his leadership in the development of a national cancer research framework, and for his contributions to our understanding of tumour viruses and cell division regulation.
Philip Branton is one of our nation’s most influential cancer research strategists. As the director of the Institute of Cancer Research of the Canadian Institutes of Health Research, he spearheaded the integration of all 30 Canadian cancer research agencies to create a single strategic planning organization. He also implemented initiatives to spur collaborative research in new areas of oncology research, including tumour banking and palliative care. A professor of biochemistry at McGill University, he has made internationally recognized contributions to our understanding of the mechanisms by which normal cells become malignant.